Guggenheim acted as sole book running manager for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IFRX:
- InflaRx announces ordinary shares and warrants offering, no amount given
- InflaRx Secures EU Approval for GOHIBIC in Treating COVID-19-Induced ARDS
- InflaRx announces EC grants marketing authorization to Gohibic for ARDS
- InflaRx Begins Phase 2a Trial for Innovative Anti-Inflammatory Drug
- InflaRx announces first patient dosed in 2a study of CSU, HS
Questions or Comments about the article? Write to editor@tipranks.com